244 related articles for article (PubMed ID: 22826208)
21. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
22. Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families.
Harvey SL; Milne RL; McLachlan SA; Friedlander ML; Birch KE; Weideman P; ; Goldgar D; Hopper JL; Phillips KA
Breast Cancer Res Treat; 2011 Dec; 130(3):1057-61. PubMed ID: 21850394
[TBL] [Abstract][Full Text] [Related]
23. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
[TBL] [Abstract][Full Text] [Related]
24. Disparities in BRCA testing: when insurance coverage is not a barrier.
Olaya W; Esquivel P; Wong JH; Morgan JW; Freeberg A; Roy-Chowdhury S; Lum SS
Am J Surg; 2009 Oct; 198(4):562-5. PubMed ID: 19800469
[TBL] [Abstract][Full Text] [Related]
25. Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation.
Hamann HA; Croyle RT; Venne VL; Baty BJ; Smith KR; Botkin JR
Am J Med Genet; 2000 May; 92(1):25-32. PubMed ID: 10797419
[TBL] [Abstract][Full Text] [Related]
26. Surgical decisions made by 158 women with hereditary breast cancer aged <50 years.
Evans DG; Lalloo F; Hopwood P; Maurice A; Baildam A; Brain A; Barr L; Howell A
Eur J Surg Oncol; 2005 Dec; 31(10):1112-8. PubMed ID: 16005602
[TBL] [Abstract][Full Text] [Related]
27. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact.
Wevers MR; Hahn DE; Verhoef S; Bolhaar MD; Ausems MG; Aaronson NK; Bleiker EM
Patient Educ Couns; 2012 Oct; 89(1):89-95. PubMed ID: 22543000
[TBL] [Abstract][Full Text] [Related]
29. 'Indirect' BRCA1/2 testing: a useful approach in hereditary breast and ovarian cancer families without a living affected relative.
Cruger DG; Kruse TA; Gerdes AM
Clin Genet; 2005 Sep; 68(3):228-33. PubMed ID: 16098011
[TBL] [Abstract][Full Text] [Related]
30. Cancer worry in women with hereditary risk factors for breast cancer.
Loescher LJ
Oncol Nurs Forum; 2003; 30(5):767-72. PubMed ID: 12949589
[TBL] [Abstract][Full Text] [Related]
31. Attitude towards genetic testing for breast cancer susceptibility: a comparison of affected and unaffected women.
Bruno M; Digennaro M; Tommasi S; Stea B; Danese T; Schittulli F; Paradiso A
Eur J Cancer Care (Engl); 2010 May; 19(3):360-8. PubMed ID: 19912305
[TBL] [Abstract][Full Text] [Related]
32. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
[TBL] [Abstract][Full Text] [Related]
33. No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result.
Dorval M; Gauthier G; Maunsell E; Dugas MJ; Rouleau I; Chiquette J; Plante M; Laframboise R; Gaudet M; Bridge PJ; Simard J
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2862-7. PubMed ID: 16365001
[TBL] [Abstract][Full Text] [Related]
34. Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer.
Peters N; Domchek SM; Rose A; Polis R; Stopfer J; Armstrong K
Genet Test; 2005; 9(1):48-53. PubMed ID: 15857187
[TBL] [Abstract][Full Text] [Related]
35. Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.
Foster C; Evans DG; Eeles R; Eccles D; Ashley S; Brooks L; Cole T; Cook J; Davidson R; Gregory H; Mackay J; Morrison PJ; Watson M
Genet Test; 2004; 8(1):23-9. PubMed ID: 15140371
[TBL] [Abstract][Full Text] [Related]
36. Psychological distress in women at risk for hereditary breast cancer: the role of family communication and perceived social support.
den Heijer M; Seynaeve C; Vanheusden K; Duivenvoorden HJ; Bartels CC; Menke-Pluymers MB; Tibben A
Psychooncology; 2011 Dec; 20(12):1317-23. PubMed ID: 20925135
[TBL] [Abstract][Full Text] [Related]
37. Decision-making about genetic testing among women at familial risk for breast cancer.
Jacobsen PB; Valdimarsdottier HB; Brown KL; Offit K
Psychosom Med; 1997; 59(5):459-66. PubMed ID: 9316177
[TBL] [Abstract][Full Text] [Related]
38. Counseling high-risk women about breast cancer.
LeGrazie B
Oncology (Williston Park); 2011 Feb; 25(2 Suppl Nurse Ed):30-5. PubMed ID: 25373281
[TBL] [Abstract][Full Text] [Related]
39. Psychometric testing of the decisional conflict scale: genetic testing hereditary breast and ovarian cancer.
Katapodi MC; Munro ML; Pierce PF; Williams RA
Nurs Res; 2011; 60(6):368-77. PubMed ID: 22048556
[TBL] [Abstract][Full Text] [Related]
40. Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.
Tercyak KP; Peshkin BN; Demarco TA; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Schwartz MD
Genet Test; 2007; 11(3):249-55. PubMed ID: 17949286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]